摘要 | 第5-7页 |
Abstract | 第7-9页 |
Introduction | 第12-23页 |
0.1 Background and Purpose of the Study | 第13-14页 |
0.2 Definition of Key Term | 第14-15页 |
0.3 Scope of Problem | 第15-17页 |
0.3.1 Scope of Study | 第17页 |
0.4 LITERATURE REVIEW | 第17-21页 |
0.5 METHODOLOGY | 第21-22页 |
0.6 Theoretical Approach | 第22-23页 |
1 A Blueprint of Counterfeit Drug Trade in Nigeria | 第23-30页 |
1.1 The Size and History of Nigeria’s Fake Drug Market | 第23-25页 |
1.2 The Backbones of Pharmaceutical Counterfeiting | 第25-30页 |
1.2.1 Drug Manufacturers | 第25-26页 |
1.2.2 Drug Importers/Wholesalers/Retailers | 第26页 |
1.2.3 Drug Professionals (The Pharmacists) | 第26-27页 |
1.2.4 Informal Drug Sellers | 第27-28页 |
1.2.5 Consumers | 第28页 |
1.2.6 The Controller | 第28-30页 |
2 The Routes and Motivating Factors Influencing Drug Trade In Nigeria | 第30-39页 |
2.1 Production and Distribution | 第30-31页 |
2.2 Costs of Medicines | 第31-32页 |
2.3 Reasons for the Increase in Production and Demand Substandard Drugs | 第32-39页 |
2.3.1. Non-professionals in drug business | 第33-34页 |
2.3.2 Drug distribution networks | 第34-35页 |
2.3.3 Poor Implementation of Drug Laws/Inadequate Legislation | 第35-36页 |
2.3.4 Low Literacy Level | 第36页 |
2.3.5. Inefficient Cooperation between Stakeholders | 第36-37页 |
2.3.6 Illegal Drug Importation | 第37页 |
2.3.7 Corruption and Greed | 第37页 |
2.3.8 High Cost of Good Quality Drugs | 第37-38页 |
2.3.9 Demand Exceeding Supply | 第38-39页 |
3 Overview some of Prominent illnesses: The Case of HIV/AIDS in Africa | 第39-57页 |
3.1 Major Diseases affecting the Population | 第40-41页 |
3.1.1 Malaria | 第40页 |
3.1.2 Tuberculosis (TB) | 第40-41页 |
3.2 The Case of HIV/AIDS and Fight Against fake Antiretroviral | 第41-48页 |
3.2.1 The Advent of HIV & AIDS in Africa | 第41-45页 |
3.2.2 Social Stigma and despondency | 第45页 |
3.2.3 Government Responses to AIDS | 第45-47页 |
3.2.4 Global response to AIDS in Africa | 第47-48页 |
3.3 Southern Africa and the Fight for Treatment | 第48-56页 |
3.4 Nigeria and the spread of fake Antiretroviral | 第56-57页 |
4 Nigeria’s Battle Against Counterfeited Pharmaceuticals | 第57-73页 |
4.1 Functions of Various Units in NAFDAC: | 第58-60页 |
4.2 NAFDAC VS Fake Drugs Within The Legal Market: | 第60-69页 |
4.2.1 Inspection Process as a Check to Drug Faking | 第60-61页 |
4.2.2 Other Interventions for Inspection by NAFDAC | 第61-62页 |
4.2.3 Implementations Of Product Registration | 第62-63页 |
4.2.4 Enforcement Activities as a Check to Drug Faking | 第63-64页 |
4.2.5 Interventions from NAFDAC Enforcement | 第64-66页 |
4.2.6 Public Enlightenment Programs | 第66页 |
4.2.7 Enforcement of NAFDAC Public Enlightenment Programs | 第66-69页 |
4.3 The Pharmaceutical Council of Nigeria Vs Fake Drugs | 第69页 |
4.4 Pharmaceutical Companies | 第69-70页 |
4.5 Drugs Dealers | 第70页 |
4.6 Customs | 第70-73页 |
5 Conclusion and Recommendations | 第73-83页 |
5.1 Shortcomings by Institutions In the Fight against Counterfeit drugs | 第73-75页 |
5.2 Proposed Solutions to the Crisis | 第75-83页 |
5.2.1 For the Government/NAFDAC | 第78-81页 |
5.2.2 Manufacturers and Drug dealers | 第81页 |
5.2.3 Pharmacists society of Nigeria (PSN) | 第81-82页 |
5.2.4 Consumers/buyers | 第82-83页 |
REFERENCES | 第83-88页 |
List of Acronyms | 第88-90页 |
Acknowledgements | 第90-91页 |
Resume | 第91-92页 |